Back to REGN

REGENERON PHARMACEUTICALS, INC. Intangible Assets 2021-2026 | REGN

Beta

What is intangible assets?

Intangible assets include non-physical assets such as patents, trademarks, copyrights, and customer relationships.

What is REGENERON PHARMACEUTICALS, INC.'s current intangible assets?

REGENERON PHARMACEUTICALS, INC. (REGN) annual intangible assets for 2025 was $1.26B, a 9.47% increase from 2024. REGENERON PHARMACEUTICALS, INC. intangible assets for the quarter ending March 31, 2026 was $1.29B.

What was REGENERON PHARMACEUTICALS, INC.'s intangible assets in 2024?

REGENERON PHARMACEUTICALS, INC. annual intangible assets for 2024 was $1.15B, a 10.59% increase from 2023.

What was REGENERON PHARMACEUTICALS, INC.'s intangible assets in 2023?

REGENERON PHARMACEUTICALS, INC. annual intangible assets for 2023 was $1.04B, a 13.45% increase from 2022.

What is REGENERON PHARMACEUTICALS, INC.'s 4-year intangible assets CAGR?

REGENERON PHARMACEUTICALS, INC. intangible assets grew at a compound annual growth rate (CAGR) of 270.13% from FY2021 to FY2025, going from $6.7M to $1.26B over 4 years.

Intangible Assets History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Growing
CAGR+270.1%
FY2021
$6.7M
FY2025
$1.26B
2122232425
4 years selected
Intangible Assets History
PeriodValueChangeSource
FY2025$1.26B+9.5%10-K
FY2024$1.15B+10.6%10-K
FY2023$1.04B+13.4%10-K
FY2022$915.5M+13564.2%10-K
FY2021$6.7M-10-K
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →